Listed Jul 2 via RAAQ SPAC at ~$10 trust value; opened weak then recovered to $12–13 range. 4-day range $11.60–$13.78. Pre-money deal valuation ~$1.8B; at $12.50 implied market cap ~$3.2B — rich vs €31M revenue but funded + commercially proven vs most quantum peers.
BusinessSuperconducting full-stack quantum computers · First European quantum company on a major US exchange (Nasdaq Jul 2, 2026) · 23 systems sold worldwide · €31M 2025 revenue · €67M+ backlog · €337M pro forma cash — Production Quantum on-premises model for research, government & enterprise
Thesis
IQMX is the first European quantum computing company on a major US exchange — listed Jul 2, 2026 via SPAC merger with Real Asset Acquisition Corp. (RAAQ) at a ~$1.8B pre-money valuation with €337M pro forma cash. Unlike most quantum peers, IQM has real commercial traction: €31M 2025 revenue, 23 quantum computers sold (claimed most of any manufacturer), and €67M+ backlog. The turbo thesis is a sector re-rating play: newly public quantum names with government validation have historically made 200–300%+ moves (IonQ post-SPAC 2021, RGTI/QBTS May 2026 federal quantum awards). IQMX was NOT in the May 2026 $2B CHIPS quantum equity round — inclusion or a major EU/US government contract win is the binary moonshot catalyst. First earnings as a public company (~Sep 2026) is the nearest hard date. Position size: 2–5% max only.
📝 Primary Verdict · Core Holding
SPECULATIVEMoonshot
Moonshot SPECULATIVE — 2–5% max. Scale in at $12.50 now or $11–11.80 dip. Base $20 (+60%), Bull $28 (+124%), Moon $47.50 (+280%) on gov contract + sector re-rating. First earnings ~Sep 2026 is the catalyst clock.
88
score / 100 ⓘ
⚡ Catalyst
📈 First Earnings as Public Company — Q3 20269 WEEKS
First quarterly report post-Nasdaq listing. Investors will scrutinize €31M revenue run-rate, €67M backlog conversion, gross margins on full-stack system deliveries, and cash burn vs €337M runway. A beat-and-raise on system orders would validate the $3.2B market cap and could trigger a quantum-sector-style reflexive re-rate.
Sep 15, 2026
🏛️ US/EU Government Quantum Contract Wave — H2 2026H2 2026
May 2026: US Commerce Dept awarded ~$2B across 9 quantum companies (equity stakes), sending D-Wave +33%, Rigetti +30%, Infleqtion +31% in a single day. IQMX was excluded — but as the first European superconducting quantum name on Nasdaq with 23 deployed systems, it is a credible candidate for a future CHIPS/NATO/EU quantum procurement round. A named award = binary 30–50%+ single-day move.
H2 2026
⚡ Fault-Tolerant Roadmap MilestoneH2 2026
IQM is deploying proceeds toward fault-tolerant quantum computing — the industry's holy grail. A demonstrated error-correction or qubit-scaling milestone (targeted H2 2026 per merger filings) would differentiate IQM from pre-revenue quantum SPACs and justify a peer-multiple re-rating toward IonQ/Rigetti levels.
H2 2026
🚀 Nasdaq Listing Completed — Jul 2, 2026DONE
SPAC merger with RAAQ closed; ADSs trading under IQMX. €198.7M net proceeds from transaction + PIPE. Dual-listing on Helsinki Stock Exchange. First European quantum on a major US exchange — index inclusion and institutional discovery phase now underway.
Jul 2, 2026
🎯 Entry Point
Entry 1
$12.50
Current price — 4 days post-listing, above SPAC $10 floor. Valid for 2–3% starter.Now (2–3% max)
Entry 2PREFERRED
$11–11.8
Post-listing dip zone near day-1 lows ($11.60). Best R/R before first earnings.If dips
Entry 3
$9.50
SPAC trust-value area — high-conviction add only if sector sells offDeep dip
✅ Take Profit
TP1
Base — revenue-scale re-rate to peer multiples on €40M+ 2026 revenue trajectory
$20
+60%
TP2
Bull — first earnings beat + backlog acceleration without gov award
Assesses how Fed policy / interest rates / inflation affect this stock — LOW = minimal risk, HIGH = proceed with caution
Rate Outlook
Quantum federal funding (CHIPS Act, DARPA, EU Quantum Flagship) flows through multi-year appropriations — largely independent of FOMC rate decisions. IQM's €337M cash runway insulates near-term operations from rate sensitivity.
Inflation
Hardware R&D and superconducting fab costs are personnel- and materials-heavy — moderate wage-inflation sensitivity, offset by government-adjacent contract pricing power.
Sector Impact
MEDIUM. IQM's real revenue base is more resilient than pre-revenue quantum peers, but the $3.2B listing valuation is still a high-multiple growth name — hawkish Fed backdrop compresses sentiment-driven quantum multiples even when policy tailwinds stay intact.
Summary
Fed risk LOW for operations (cash-rich, gov-funded sector). Valuation risk MEDIUM — newly listed at ~100x sales means multiple compression is the bigger threat than macro, unless a government contract or earnings beat triggers sector re-rating.
🎯 Analyst Targets
Wall Street price targets vs the current price — cross-check our TP levels
SPAC Deal Implied (pre-money)
Reference$10-20%
Peer Revenue Multiple (IonQ/RGTI implied)
Implied Base$22+76%
Government Validation Scenario
Implied Bull$35+180%
current price $12.50
🔍 Similar-Catalyst Comparable Check
Stocks that went through similar catalyst events — calibrate whether the +30%+ target is realistic
IONQ✅ GoodNov 2021
+193%
in 45 days
Post-SPAC Listing Run — First Pure-Play Quantum IPO
IonQ listed via SPAC at $10.60 (Oct 2021) and surged to $31 by Nov 17 — +193% in 45 days as the first pure-play quantum public company. IQMX is the first European quantum on Nasdaq with stronger commercial metrics (€31M revenue vs IonQ's ~$2M at debut). The sector discovery re-rate playbook is directly comparable.
RGTI✅ GoodMay 2026
+57%
in 2 days
US Commerce Dept CHIPS Quantum Equity-Stake LOI ($100M)
Rigetti +30.6% on May 21 and ~+57% over two sessions on $100M CHIPS Act LOI with equity stake. Superconducting quantum peer to IQM. IQMX's moon case assumes similar federal validation — a named award would likely produce a comparable violent re-rate.
QBTS✅ GoodMay 2026
+33%
in 1 day
Same $2B Federal Quantum Equity Program
D-Wave Quantum +33% in a single day on May 21, 2026 CHIPS quantum award announcement. Confirms the sector-wide repricing magnitude when any quantum name lands direct US government equity investment. IQMX was not in this round — inclusion in a future tranche is the clearest moonshot trigger.
⚡ Optional Layer · Tactical Overlay
🎯 Catalyst Spot Mode
Short-term play around the catalyst (Sep 2026 earnings) only — an optional overlay, not a verdict that ranks equal to the Core Holding.
⚠️
Use this stop-loss set (-20% / -35%) only when trading the earnings spot — not for the core holding (use the -20% / -50% set above). If you are holding long-term, follow the core set.
📈Pre-Catalyst Run-up Pattern
+15–40%4–8 สัปดาห์ก่อน first public earnings (~Sep 2026)
Newly listed quantum names run 15–40% in the 2–4 weeks before first earnings as institutions build positions and retail discovers the ticker. IonQ ran +25% in the month before its first post-SPAC earnings. IQMX's 4-day trading history means the pre-earnings run hasn't started yet.
🎲Historical Post-Catalyst Move
✅ Catalyst Winavg +57%
range: +30% to +57%· May 2026
May 21–22, 2026: Rigetti +30.6% day-one and ~+57% over two sessions on $100M CHIPS Act LOI — the benchmark for what happens when a superconducting quantum name lands direct federal validation. IonQ post-SPAC Nov 2021: +193% in 45 days from $10.60 to $31.
❌ Catalyst Missavg -35%
range: -20% to -50%· 2022
IonQ fell from $31 ATH (Nov 2021) back to ~$3 by Dec 2022 (-90%) when revenue missed SPAC projections. SPAC quantum names without follow-through de-rate violently. IQMX day-one dip to $11.60 (-14% from highs) shows early volatility.
💼Spot Position Sizing
How the recommended % is derived
4%
of portfolio
4% max — higher than pure ค่าขนม (2–3%) because IQM has real €31M revenue + €337M cash (not pre-revenue hype), but still binary on gov contract inclusion and first earnings. Wider than core but below catalyst-list sizing.
🛑Stop Loss · Spot Trade
Spot cut-loss levels — separate from the core holding